Histiocitosis de células de Langerhans. Avances en la patogenia y práctica clínica

Astigarraga, Itziar; García-Obregón, Susana; Pérez-Martínez, Antonio; Gutiérrez-Carrasco, Ignacio; Santa-María, Vicente; Rodríguez-Vigil Iturrate, Carmen; Lorite Reggiori, Mikael; Murciano Carrillo, Thais; Torrent, Montse.
An. pediatr. (2003. Ed. impr.) ; 97(2): 130.e1-130.e7, ago, 2022. ilus
Artículo en Inglés, Español | IBECS (España) | ID: ibc-207564

Documentos relacionados

  1. Circulating senescent myeloid cells infiltrate the brain and cause neurodegeneration in histiocytic disorders.
  2. Treatment of congenital Langerhans cell histiocytosis with cobimetinib.
  3. [LANGERHANS CELL HISTIOCYTOSIS: A SINGLE CENTER EXPERIENCE IN THE PEDIATRIC HEMATO-ONCOLOGY DIVISION OF THE TEL-AVIV SOURASKY MEDICAL CENTER].
  4. The changing landscape of pediatric histiocytoses: Birth, life, and transdifferentiation of pediatric histiocytes.
  5. [Isolated liver involvement in Langerhans cell histiocytosis: A case report].
  6. Eye movement abnormalities in neurodegenerative langerhans cell histiocytosis.
  7. [Clinical and morphological analysis of Langerhans cell histiocytosis in a child of early age].
  8. The coming of age of Langerhans cell histiocytosis.
  9. International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults.
  10. [Updated AWMF Guideline on the Diagnosis and Treatment of Langerhans cell Histiocytosis in Children and Adolescents].